Optimi Health's Psilocybin Capsules Selected for Medibank Insurance ProgramAustralia's largest private health insurer expands its AUD $10M psychotherapy program to cover psilocybin for Treatment-Resistant Depression, building on earlier MDMA coverage for PTSDOctober 06, 2025 7:00 AM EDT | Source: Optimi Health Corp.Vancouver, British Columbia--(Newsfile Corp. - October 6, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian GMP-compliant man ...